Book contents
- Subfertility, Reproductive Endocrinology and Assisted Reproduction
- Subfertility, Reproductive Endocrinology and Assisted Reproduction
- Copyright page
- Contents
- Contributors
- Chapter 1 The Patient’s Perspective
- Chapter 2 Epidemiology of Infertility
- Chapter 3 Investigation of Male Infertility
- Chapter 4 Female Fertility
- Chapter 5 Unexplained Infertility
- Chapter 6 Overview of Management of Male Infertility
- Chapter 7 Semen Analysis and Sperm Function Tests
- Chapter 8 Assessment of Fallopian Tube Patency
- Chapter 9 Endometriosis
- Chapter 10 Congenital Uterine Abnormalities
- Chapter 11 Fibroids and Fertility
- Chapter 12 Tubal Factor Infertility and Tubal Surgery
- Chapter 13 Fertility and the Hypogonadal Male
- Chapter 14 Causes and Investigation of Ovarian Infertility
- Chapter 15 Ovulation Induction for Anovulatory Infertility
- Chapter 16 The Role of Regulation in Reproductive Medicine
- Chapter 17 Common Stimulation Regimens in Assisted Reproductive Technology
- Chapter 18 Oocyte Retrieval and Embryo Transfer
- Chapter 19 Gamete Preparation and Embryo Culture
- Chapter 20 Single Embryo Transfer
- Chapter 21 The Risks of Assisted Reproduction
- Chapter 22 Gamete and Embryo Cryopreservation
- Chapter 23 Quality Management in Reproductive Medicine
- Chapter 24 Early Pregnancy
- Chapter 25 Evaluation and Management of Recurrent Miscarriage
- Chapter 26 Sperm Retrieval
- Chapter 27 Preimplantation Genetic Testing
- Chapter 28 Adjuvant Treatment and Alternative Therapies to Improve Fertility
- Chapter 29 Male Fertility Preservation
- Chapter 30 Female Fertility Preservation
- Chapter 31 Donor Recruitment
- Chapter 32 Gamete Donation
- Chapter 33 Training Opportunities in Reproductive Medicine
- Index
- References
Chapter 21 - The Risks of Assisted Reproduction
Published online by Cambridge University Press: 03 June 2019
- Subfertility, Reproductive Endocrinology and Assisted Reproduction
- Subfertility, Reproductive Endocrinology and Assisted Reproduction
- Copyright page
- Contents
- Contributors
- Chapter 1 The Patient’s Perspective
- Chapter 2 Epidemiology of Infertility
- Chapter 3 Investigation of Male Infertility
- Chapter 4 Female Fertility
- Chapter 5 Unexplained Infertility
- Chapter 6 Overview of Management of Male Infertility
- Chapter 7 Semen Analysis and Sperm Function Tests
- Chapter 8 Assessment of Fallopian Tube Patency
- Chapter 9 Endometriosis
- Chapter 10 Congenital Uterine Abnormalities
- Chapter 11 Fibroids and Fertility
- Chapter 12 Tubal Factor Infertility and Tubal Surgery
- Chapter 13 Fertility and the Hypogonadal Male
- Chapter 14 Causes and Investigation of Ovarian Infertility
- Chapter 15 Ovulation Induction for Anovulatory Infertility
- Chapter 16 The Role of Regulation in Reproductive Medicine
- Chapter 17 Common Stimulation Regimens in Assisted Reproductive Technology
- Chapter 18 Oocyte Retrieval and Embryo Transfer
- Chapter 19 Gamete Preparation and Embryo Culture
- Chapter 20 Single Embryo Transfer
- Chapter 21 The Risks of Assisted Reproduction
- Chapter 22 Gamete and Embryo Cryopreservation
- Chapter 23 Quality Management in Reproductive Medicine
- Chapter 24 Early Pregnancy
- Chapter 25 Evaluation and Management of Recurrent Miscarriage
- Chapter 26 Sperm Retrieval
- Chapter 27 Preimplantation Genetic Testing
- Chapter 28 Adjuvant Treatment and Alternative Therapies to Improve Fertility
- Chapter 29 Male Fertility Preservation
- Chapter 30 Female Fertility Preservation
- Chapter 31 Donor Recruitment
- Chapter 32 Gamete Donation
- Chapter 33 Training Opportunities in Reproductive Medicine
- Index
- References
Summary
Assisted reproductive techniques (ART) are now responsible for more than 2% of all human births in the United Kingdom and closer to 5% in mainland Europe. According to the Human Fertilisation and Embryology Authority (HFEA), 63,600 cycles of treatment were performed in 2013 alone in the United Kingdom [1]. Despite being so common, the ART ‘industry’ remains one of the most tightly regulated branches of medicine – and probably not without due reason as the consequences of error are potentially huge. This chapter deals, though, with the medical complications of the treatment process and not the ‘social’ complications of embryo mishandling.
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2019